GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » Capex-to-Revenue

Swedencare AB (Swedencare AB) Capex-to-Revenue : 0.01 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Swedencare AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Swedencare AB's Capital Expenditure for the three months ended in Mar. 2024 was $-0.83 Mil. Its Revenue for the three months ended in Mar. 2024 was $57.52 Mil.

Hence, Swedencare AB's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.01.


Swedencare AB Capex-to-Revenue Historical Data

The historical data trend for Swedencare AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedencare AB Capex-to-Revenue Chart

Swedencare AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 - 0.04 0.04 0.02

Swedencare AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.01

Competitive Comparison of Swedencare AB's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Swedencare AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swedencare AB's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Swedencare AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Swedencare AB's Capex-to-Revenue falls into.



Swedencare AB Capex-to-Revenue Calculation

Swedencare AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-3.519) / 227.958
=0.02

Swedencare AB's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.826) / 57.524
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Swedencare AB  (OTCPK:SWDCF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Swedencare AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Swedencare AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Swedencare AB (Swedencare AB) Business Description

Traded in Other Exchanges
Address
Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 205 12
Swedencare AB is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.

Swedencare AB (Swedencare AB) Headlines

No Headlines